Chen, Youlu
Chen, Zuoguan
Duan, Jianwei
Gui, Liang
Li, Huiyang
Liang, Xiaoyu
Tian, Xinxin
Liu, Kaijing
Li, Yongjun
Yang, Jing http://orcid.org/0000-0003-3848-5958
Funding for this research was provided by:
the National Natural Science Foundation of China (82072080, 31771097, 81870351)
CAMS Innovation Fund for Medical Sciences (2017-12M-1-016, 2018-12M-1-002)
Tianjin Research Program of Application Foundation and Advanced Technology ((17JCZDJC37400)
National Key Research and Development Project (2018YFC2000300)
PUMC Discipline Construction Project (201920102101)
the Special Program for High-Tech Leader & Teams of Tianjin Government
the Tianjin innovation Promotion Plan Key Innovation Team of Immunoreactive Biomaterials
Article History
Received: 19 October 2021
Accepted: 24 February 2022
First Online: 19 March 2022
Declarations
:
: All animal experiments were carried out in accordance with the relevant guidelines and regulations approved by the Center of Tianjin Animal Experiment ethics committee and authority for animal protection. (License for use of experimental animals: Approval No.: SYXK (Jin):2019–0002).
: All the authors agree with the publication.
: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.